# Patent Draft: Genome Compilation from Behavioral Failures
## Candidate G — Priority #3 (MEDIUM-HIGH)

**Applicant:** ENERGENAI LLC | UEI: LBZFEH87W746
**Inventor(s):** Jason [TBD — full legal name required]
**Status:** Draft in progress
**Created:** 2026-02-27

---

## Title (Working)

"System and Method for Compiling a Behavioral Genome from Failure Patterns in Autonomous AI Agents Using Immune-System-Inspired Encoding"

## Abstract (Draft)

A system and method for building a persistent, evolving behavioral genome in autonomous AI agents through a four-stage pipeline: (1) detecting behavioral failure patterns during agent operation, (2) encoding detected failures as immune-system-style antibodies — structured rules that recognize and prevent recurrence of specific failure classes, (3) compiling encoded antibodies during sleep or consolidation cycles into a coherent genome structure, and (4) persisting the genome as a durable, evolving behavioral specification that governs future agent behavior. The genome serves as a living document of learned avoidance behaviors, analogous to an organism's immune memory, enabling agents to develop increasingly robust behavioral repertoires over time without explicit human programming.

## Key Claims (Draft — Requires Patent Counsel Review)

1. A computer-implemented method for developing behavioral resilience in an autonomous AI agent, comprising:
   - monitoring agent operations and detecting behavioral failure patterns, including failed tool calls, rejected outputs, error states, and negative feedback signals;
   - encoding each detected failure pattern as an antibody data structure containing: a pattern signature identifying the failure class, a trigger condition specifying when the antibody activates, and a response action specifying the alternative behavior;
   - during a consolidation cycle, compiling accumulated antibodies into a genome structure that organizes antibodies by failure domain, resolves conflicts between overlapping antibodies, and establishes priority ordering;
   - persisting the compiled genome and loading it into the agent's operational context on subsequent execution cycles.

2. The method of claim 1, wherein the genome evolves over time through:
   - adding new antibodies from newly detected failures;
   - strengthening antibodies that successfully prevent failure recurrence;
   - weakening or removing antibodies that trigger false positives;
   - merging related antibodies into generalized behavioral rules.

3. The method of claim 1, wherein the consolidation cycle is triggered by idle-cycle detection as described in related application [F — cross-reference].

4. A persistent behavioral genome data structure for an autonomous AI agent, comprising an ordered collection of antibody records, each encoding a failure pattern and its corresponding avoidance behavior, organized into functional domains and maintained across agent restarts.

## Prior Art Differentiation

| Prior Art | Their Approach | Our Distinction |
|-----------|---------------|-----------------|
| Reflexion (NeurIPS 2023) | Verbal reinforcement from failures in episodic buffer | Structured antibody encoding + genome compilation |
| Letta sleep agents (2024-25) | Sleep-phase consolidation | Failure-specific genome pipeline, not general consolidation |
| AIS literature (1990s+) | Antibody encoding for cybersecurity | Applied to AI agent behavioral learning, not intrusion detection |
| CN101930517B | Antibody gene detection for security | Different domain, no agent behavioral genome |
| EvolveR (2025) | Experience-driven lifecycle with RL | Immune metaphor + genome structure, not RL-based |

## Implementation Reference

- `/root/entity/src/agent/loop.ts` — Failure detection in agent cycle
- `/root/entity/src/agent/tools.ts` — Tool call error tracking
- `/root/entity/src/agent/system-prompt.ts` — Behavioral directives (proto-genome)
- `/root/.automaton/memory.db` — Memory persistence layer

## Files in This Directory

- `README.md` — This file
- `claims-draft.md` — Detailed claim language (TBD)
- `figures/` — Patent figures (TBD)
- `prior-art-search.md` — Expanded prior art findings (from search agent)
- `specification-draft.md` — Full specification (TBD)

## Next Steps

1. Engage patent counsel
2. Complete prior art verification (search agent running)
3. Draft full specification with genome pipeline diagrams
4. Consider cross-referencing with Candidate F (idle-triggered consolidation)
5. Prepare provisional application
